Metabolic Disorders and Hepatitis: Insights from a Mendelian Randomization Study

Overview

Journal World J Gastrointest Surg

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2024 Jul 10

PMID 38983337

Authors

Ling-Bo Liang

Xiang-Ping Liu

Ting-Rui Mao

Qiao-Li Su

Affiliations

Soon will be listed here.

Abstract

Background: Hepatitis is a systemic disease that often results in various comorbidities. Meta-bolic disorders, the most common comorbidities in clinical practice, were selected for this study.

Aim: To investigate the causal relationship between comorbidities and hepatitis trea-tment outcomes.

Methods: A total of 23583378 single nucleotide polymorphisms from 1248743 cases and related summaries of genome-wide association studies were obtained from online public databases. A two-sample Mendelian randomization (MR) was performed to investigate causality between exposure [type 2 diabetes mellitus (T2D), hyperlipidemia, and hypertension] and outcome (chronic hepatitis B or C in-fections).

Results: The data supported the causal relationship between comorbidities and hepatitis infections, which will affect the severity of hepatitis progression and will also provide a reference for clinical researchers. All three exposures showed a link with progression of both hepatitis B (T2D, = 0.851; hyperlipidemia, = 0.596; and hypertension, = 0.346) and hepatitis C (T2D, = 0.298; hyperlipidemia, = 0.141; and hypertension, = 0.035).

Conclusion: The results of MR support a possible causal relationship between different ex-posures (T2D, hyperlipidemia, and hypertension) and chronic hepatitis progression; however, the potential mechanisms still need to be elucidated.

References

Sarin S, Kumar M, Lau G, Abbas Z, Chan H, Chen C . Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2015; 10(1):1-98. PMC: 4722087. DOI: 10.1007/s12072-015-9675-4. View

Valla D, Flejou J, Lebrec D, Bernuau J, RUEFF B, Salzmann J . Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations. Hepatology. 1989; 10(4):482-7. DOI: 10.1002/hep.1840100414. View

Simon T, Duberg A, Aleman S, Hagstrom H, Nguyen L, Khalili H . Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population. Ann Intern Med. 2019; 171(5):318-327. PMC: 8246628. DOI: 10.7326/M18-2753. View

Allison M, Wreghitt T, Palmer C, Alexander G . Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol. 1994; 21(6):1135-9. DOI: 10.1016/s0168-8278(05)80631-2. View

Yang L, Li T, Li W, Tang X, Li J, Long R . Occult Hepatitis B Virus Infection in Hyperlipidemia Patients. Tohoku J Exp Med. 2017; 241(4):255-261. DOI: 10.1620/tjem.241.255. View

Wang X, Xie Q . Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis. J Clin Transl Hepatol. 2022; 10(1):128-133. PMC: 8845159. DOI: 10.14218/JCTH.2021.00200. View

Goh M, Sinn D, Kim S, Woo S, Cho H, Kang W . Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Hepatology. 2019; 71(6):2023-2032. DOI: 10.1002/hep.30973. View

Zhu L, Jiang J, Zhai X, Baecker A, Peng H, Qian J . Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study. Liver Int. 2018; 39(1):70-80. PMC: 6309470. DOI: 10.1111/liv.13933. View

Han W, Huang C, Ji Y, Zhou L, Chen J, Hou J . Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus. Front Med (Lausanne). 2022; 8:805029. PMC: 8724037. DOI: 10.3389/fmed.2021.805029. View

10.

Zhang H, Tu T . Approaches to quantifying hepatitis B virus covalently closed circular DNA. Clin Mol Hepatol. 2021; 28(2):135-149. PMC: 9013611. DOI: 10.3350/cmh.2021.0283. View

11.

Hsu P, Wei Y, Liang P, Jia-Jung Lee , Niu S, Huang J . Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis. J Gastroenterol Hepatol. 2021; 36(8):2261-2269. DOI: 10.1111/jgh.15480. View

12.

Chang F, Wang Y, Lang H, Tsai C, Hou M, Lee F . Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study. Hepatology. 2017; 66(3):896-907. DOI: 10.1002/hep.29172. View

13.

Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

14.

Gantumur G, Batsaikhan B, Huang C, Yeh M, Huang C, Lin Y . The association between hepatitis C virus infection and renal function. J Chin Med Assoc. 2021; 84(8):757-765. DOI: 10.1097/JCMA.0000000000000561. View

15.

Merza M . Seroprevalence and risk factors of hepatitis B and C viruses among diabetes mellitus patients in Duhok province, Iraqi Kurdistan. J Family Med Prim Care. 2020; 9(2):642-646. PMC: 7114067. DOI: 10.4103/jfmpc.jfmpc_1158_19. View

16.

Fujinaga K, Usui M, Yamamoto N, Ishikawa E, Nakatani A, Kishiwada M . Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation: significance of renal biopsy. Transplant Proc. 2014; 46(3):804-10. DOI: 10.1016/j.transproceed.2013.11.103. View

17.

Kurki M, Karjalainen J, Palta P, Sipila T, Kristiansson K, Donner K . FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023; 613(7944):508-518. PMC: 9849126. DOI: 10.1038/s41586-022-05473-8. View

18.

Hartwig F, Borges M, Horta B, Bowden J, Davey Smith G . Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study. JAMA Psychiatry. 2017; 74(12):1226-1233. PMC: 6583386. DOI: 10.1001/jamapsychiatry.2017.3191. View

19.

Lee K, Lim C . Mendelian Randomization Analysis in Observational Epidemiology. J Lipid Atheroscler. 2020; 8(2):67-77. PMC: 7379124. DOI: 10.12997/jla.2019.8.2.67. View

20.

Parrilli G, Manguso F, Orsini L, Coccoli P, Vecchione R, Terracciano L . Essential hypertension and chronic viral hepatitis. Dig Liver Dis. 2007; 39(5):466-72. DOI: 10.1016/j.dld.2007.01.009. View